Celecoxib vs Placebo as Adjuvant Therapy Among Patients With Breast Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
JAMA Oncology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Effect of Celecoxib vs Placebo as Adjuvant Therapy on Disease-Free Survival Among Patients With Breast Cancer: The REACT Randomized Clinical Trial
JAMA Oncol 2021 Jul 15;[EPub Ahead of Print], RC Coombes, H Tovey, L Kilburn, J Mansi, C Palmieri, J Bartlett, J Hicks, A Makris, A Evans, S Loibl, C Denkert, E Murray, R Grieve, R Coleman, A Borley, M Schmidt, B Rautenberg, CA Kunze, U Rhein, K Mehta, K Mousa, T Dibble, XL Lu, G von Minckwitz, JM BlissFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.